Company Biophytis S.A. Euronext Paris

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

End-of-day quote Euronext Paris 06:00:00 2024-05-06 pm EDT 5-day change 1st Jan Change
0.85 EUR 0.00% Intraday chart for Biophytis S.A. +1.19% -58.33%

Business Summary

Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.

The company is located in Paris, France and Cambridge, Massachusetts.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,601,206 1,055,663 ( 40.58 %) 600 ( 0.0231 %) 40.58 %

Shareholders

NameEquities%Valuation
32,775,471 2.860 % 123 891 €
Gestys SA
1.953 %
22,380,000 1.953 % 84 596 €
Waly Dioh
0.0215 %
246,316 0.0215 % 931 €
Lyxor International Asset Management SAS
0.0207 %
236,829 0.0207 % 895 €
142,308 0.0124 % 538 €
Ecofi Investissements SA
0.009248 %
105,980 0.009248 % 401 €
Rob van Maanen
0.006630 %
75,983 0.006630 % 287 €
75,983 0.006630 % 287 €
Claresco Finance SA
0.002557 %
29,300 0.002557 % 111 €
Nadine Coulm
0.000109 %
1,250 0.000109 % 5 €
NameEquities%Valuation
Morgan Stanley & Co. International Plc
0.0401 %
4,600 0.0401 % 1 615 €
RhumbLine Advisers LP
0.004625 %
530 0.004625 % 186 €

Company contact information

Biophytis SA

Sorbonne Université Bâtiment A 4 ème étage

75005, Paris

+33 1 44 27 23 00

http://www.biophytis.com
address Biophytis S.A.(ALBPS)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW